Tresmares Capital has taken a minority stake in Rioja Nature Pharma
Madrid – CFI is pleased to announce that it acted as exclusive financial advisor to Rioja Nature Pharma in its sale of a minority stake to Tresmares Capital through a sharecapital increase.
Rioja Nature Pharma is a leading dietary supplements manufacturer for third parties with expected revenues of >€40M in 2023.
Tresmares Capital is a pan-European growth-focused alternative investment firm operating in Spain, the United Kingdom and Portugal. Founded in 2020 and comprising a team of 50 investment professionals, the firm offers an extensive range of financing solutions to both high-growth SMEs and their private equity backers.
This transaction closed in November 2023.
Food & Beverage & Agribusiness
has sold minority stake to
Transaction details
Leading dietary supplement provider Rioja Nature Pharma has sold a minority stake to private equity fund Tresmares Capital
Our latest transactions
Aerospace & Defence
has been acquired by
backed by
Transaction details
Aviotec, an Italian aerospace insulation and harness solutions provider, has been acquired by Canopy Aerospace & Defence, backed Trive Capital
Business Services
partners with
backed by
Transaction details
Westerduin, a Dutch staffing specialist, partners with Werkis, backed by Quadrum Capital
Business Services
has been acquired by
Transaction details
Honk & Sandström, a Swedish traffic and track safety consultant, has been acquired by railway infrastructure company group Rovik Group
Business Services
has acquired
Transaction details
Independent international consultancy R&D specialist Zabala Innovation Consulting has acquired ECDF
